| Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a … J Ma, Y Liu, XL Huang, ZY Zhang, JN Myers, DM Neskey, LP Zhong Oral oncology 48 (11), 1076-1084, 2012 | 117 | 2012 |
| Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis Y Liu, J Li, Y Tan, P Xiong, L Zhong Oral surgery, oral medicine, oral pathology and oral radiology 119 (2), 238 …, 2015 | 93 | 2015 |
| Induction chemotherapy in patients with resectable head and neck squamous cell carcinoma: a meta-analysis J Ma, Y Liu, X Yang, C Zhang, Z Zhang, L Zhong World journal of surgical oncology 11, 1-7, 2013 | 85 | 2013 |
| GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma CZ Yang, J Ma, DW Zhu, Y Liu, B Montgomery, LZ Wang, J Li, ZY Zhang, ... Annals of oncology 25 (6), 1215-1222, 2014 | 81 | 2014 |
| Study of induction chemotherapy efficacy in oral squamous cell carcinoma using pseudotargeted metabolomics G Ye, Y Liu, P Yin, Z Zeng, Q Huang, H Kong, X Lu, L Zhong, Z Zhang, ... Journal of proteome research 13 (4), 1994-2004, 2014 | 81 | 2014 |
| Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade D Zhu, Y Liu, X Yang, C Yang, J Ma, X Yang, J Qiao, L Wang, J Li, ... BMC cancer 13, 1-10, 2013 | 36 | 2013 |
| Anti-tumor effect of carrimycin on oral squamous cell carcinoma cells in vitro and in vivo S Liang, T Zhao, Z Zhou, W Ju, Y Liu, Y Tan, D Zhu, Z Zhang, L Zhong Translational Oncology 14 (6), 101074, 2021 | 25 | 2021 |
| Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial) Y Huang, J Sun, J Li, D Zhu, M Dong, S Dou, Y Tang, W Shi, Q Sun, ... International Journal of Surgery 109 (8), 2220-2227, 2023 | 17 | 2023 |
| Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for … W Ju, Y Liu, L Wang, J Li, G Ren, J Sun, W Tu, Y Hu, T Ji, W Yang, J Li, ... Cancer Communications 41 (3), 279-283, 2021 | 17 | 2021 |
| Identification of SCARA5 as a potential biomarker for oral squamous cell carcinoma using MALDI–TOF–MS analysis Y Liu, Y Tan, W Sun, W Ju, Y Fu, L Wang, J Li, C Zhang, Z Zhang, L Zhong PROTEOMICS–Clinical Applications 12 (5), 1700180, 2018 | 17 | 2018 |
| Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma T Zhao, S Liang, W Ju, Y Liu, Y Tan, D Zhu, C Zhang, Z Zhang, L Zhong Clinical Nutrition 39 (9), 2751-2758, 2020 | 13 | 2020 |
| Computed tomographic features of adenoid cystic carcinoma in the palate W Ju, T Zhao, Y Liu, Y Tan, M Dong, Q Sun, L Wang, J Li, L Zhong Cancer Imaging 19, 1-9, 2019 | 12 | 2019 |
| Diffuse-type tenosynovial giant cell tumor of the temporomandibular joint with skull base invasion: a report of 22 cases with literature review Y Liu, B Fan, Y Tan, D Zhu, M Dong, L Wang, J Li, J Sun, C Zhang, T Ji, ... Oral surgery, oral medicine, oral pathology and oral radiology 131 (1), 16-26, 2021 | 10 | 2021 |
| Clinical and pathologic analysis of myopericytoma in the oral and maxillofacial region W Ju, T Zhao, Y Liu, M Dong, L Wang, J Li, Y Tan, L Zhong Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 128 (4), 393-399, 2019 | 9 | 2019 |
| Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study W Ju, Y Zhang, Y Liu, J Sun, J Li, M Dong, Q Sun, W Shi, T Zhao, Z Zhou, ... International Journal of Surgery 109 (4), 879-886, 2023 | 5 | 2023 |
| Cyclin D1 overexpression enhances chemosensitivity to TPF chemotherapeutic agents via the caspase-3 pathway in oral cancer YJ Hu, WW Sun, TC Zhao, Y Liu, DW Zhu, LZ Wang, J Li, CP Zhang, ... Oncology Letters 20 (5), 154, 2020 | 4 | 2020 |
| Neoadjuvant trial with toripalimab, albumin paclitaxel, and cisplatin on pathological response in locally advanced resectable oral squamous cell carcinoma (Illuminate Trial). LP Zhong, Y Huang, J Sun, J Li, M Dong, G Zhu, J Li, W Ju Journal of Clinical Oncology 40 (16_suppl), e18067-e18067, 2022 | 1 | 2022 |
| Reply to “Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis—a commentary” Y Liu, L Zhong Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 121 (3), 341-343, 2016 | 1 | 2016 |
| Diagnostic accuracy of salivary gland tumors by ultrasonography Y Liu, J Li, YR Tan, P Xiong, LP Zhong Oral Surg Oral Med Oral Pathol Oral Radiol 119, 238-245, 2015 | 1 | 2015 |
| Nomogram to Predict Nodal Recurrence‐Free Survival in Early Oral Squamous Cell Carcinoma Y Liu, L Liu, Y He, W Jiang, T Fang, Y Huang, X Zhou, D Zhu, J Li, ... Oral diseases, 1354-523X , 1601-0825, 2024 | | 2024 |
